Trials / Completed
CompletedNCT02956473
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study involves the use of a common breast imaging modality (magnetic resonance imaging, 'MRI') and is investigating its role in evaluating surgical decision making for breast cancer when it is performed with the patient in a new position (lying on one's back) as opposed to in the standard position (lying on one's stomach).
Detailed description
The procedure involved is called a supine breast magnetic resonance imaging (MRI).In this study, the investigators are evaluating the value of supine MRI in surgical decision making for women with breast cancer either undergoing upfront surgery or for those anticipating surgery after receiving neoadjuvant therapy. The purpose of this study is to assess the value of supine breast MRI as a new imaging method to assist in surgical treatment planning. It is possible that the use of supine breast MRI will help your doctor see the size and location of tumors more accurately
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Supine MRI | |
| OTHER | Neoadjuvant Therapy (NAT) | |
| DEVICE | Ultrasound | |
| DEVICE | Mammography | |
| PROCEDURE | Standard of Care | |
| DEVICE | Standard MRI |
Timeline
- Start date
- 2016-11-15
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2016-11-07
- Last updated
- 2024-03-12
- Results posted
- 2024-03-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02956473. Inclusion in this directory is not an endorsement.